Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Radiopharmaceutical Theranostics Market Expected To Grow In Terms Of Size?
The market size for radiopharmaceutical theranostics has witnessed a rapid expansion in the recent past. From the year 2024 to 2025, it will witness an increase from $2.88 billion to $3.27 billion, exhibiting a compound annual growth rate (CAGR) of 13.5%. This growth in the previous period is attributed to the development in radiopharmaceuticals, advancements in clinical research, increased investment in research, regulatory approvals, and progress in nuclear medicine.
In the coming years, the market size of radiopharmaceutical theranostics is predicted to experience rapid expansion, eventually reaching $5.74 billion in 2029 with a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period is due to various factors such as biomarker discovery and validation, the development of genomic and proteomic technologies, precision radiotherapy, interdisciplinary collaborations, and patient advocacy and support. Other contributing trends include ethical and legal considerations, the use of telemedicine in theranostics, patient-centric care, the customization of radiopharmaceuticals, and the progression of nano-theranostics.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11951&type=smp
What Are The Primary Factors Supporting The Radiopharmaceutical Theranostics Market Expansion?
The surge in cancer cases is likely to fuel the expansion of the radiopharmaceutical theranostics market in the future. Cancer is a disease characterized by abnormal and complex cell growth that has the potential to infiltrate and metastasize to different parts of the body. By providing targeted and personalized treatment methods, radiopharmaceutical theranostics proves to be beneficial in fighting cancer. For instance, the American Cancer Society, a voluntary health organization based in the US, predicts about 1.9 million new cancer diagnoses and approximately 609,820 cancer-related deaths in 2023 alone. Furthermore, it is anticipated that about 88% of the diagnosed individuals will be from the age group of 50 years or older. Thus, the upsurge in cancer occurrences is a major catalyst for the progression of the radiopharmaceutical theranostics market.
Which Segmentation Categories Are Highlighted In The Radiopharmaceutical Theranostics Market Analysis?
The radiopharmaceutical theranosticsmarket covered in this report is segmented –
1) By Product Type: Alpha Emitters; Beta Emitters; Positron Emission Tomography (PET) Tracers
2) By Source: Nuclear Reactors; Cyclotrons
3) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; 18F; Y-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64; Other Radioscopes
4) By Indication: Oncology; Cardiology; Neurology; Other Indications
5) By End User: Hospitals; Diagnostic Imaging Centers; Academic And Research Institutes; Other End Users
Subsegments:
1) By Alpha Emitters: Actinium-225; Radium-223; Bismuth-213; Other Alpha-Emitting Radiopharmaceuticals
2) By Beta Emitters: Iodine-131; Lutetium-177; Yttrium-90; Other Beta-Emitting Radiopharmaceuticals
3) By Positron Emission Tomography (PET) Tracers: Fluorodeoxyglucose (FDG); Gallium-68; Carbon-11; Other PET Tracers
Which Market Trends Are Expected To Define The Future Of The Radiopharmaceutical Theranostics Market?
In an attempt to pioneer innovative treatments, key players in the radiopharmaceutical theranostics field are pursuing strategic alliances. These partnerships allow them to pool their resources and expertise, which in turn boosts their R&D capabilities, broadens their market penetration, and speeds up their commercialization processes, all of which drive growth and innovation in the radiopharmaceutical theranostics sector. For example, in March 2023, Australia’s Radiopharm Theranostics collaborated with Pharma15 Corporation, a US enterprise, to create cutting-edge therapeutic radiopharmaceuticals aimed at prostate cancer, with a special emphasis on countering resistance to existing PSMA-targeted treatments and improving selectivity to reduce toxicity in healthy tissues.
Which Organizations Are At The Forefront Of The Radiopharmaceutical Theranostics Market?
Major companies operating in the radiopharmaceutical theranostics market include Cardinal Health Inc., GE HealthCare Technologies Inc., Bayer AG, China Grand Pharmaceutical & Healthcare., Lantheus Medical Imaging Inc., Curium Pharma, Advanced Accelerator Applications, Telix Pharmaceuticals Ltd., Bracco Imaging S.p.A, NTP Radioisotopes SOC Ltd., Navidea Biopharmaceuticals Inc., Jubilant DraxImage Inc., NorthStar Medical Radioisotopes LLC, Blue Earth Diagnostics Ltd., Precirix NV, SpectronRx, Viewpoint Molecular Targeting Inc., NuView Life Sciences, Alpha-9 Theranostics Inc., RadioMedix Inc, RayzeBio Inc, Fusion Pharmaceuticals Inc, Actinium Pharmaceuticals Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, Ariceum Therapeutics GmbH, Radiopharm Theranostics Ltd, Ratio Therapeutics Inc, Primo Biotechnology, Bivision Biomedical Technology (Nanjing) Co. Ltd.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Radiopharmaceutical Theranostics Market?
North America was the largest region in the radiopharmaceutical theranostics market in 2024. The regions covered in the radiopharmaceutical theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=11951&type=smp
Browse Through More Reports Similar to the Global Radiopharmaceutical Theranostics Market 2025, By The Business Research Company
Software Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/software-products-global-market-report
Healthcare Cloud Computing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/healthcare-cloud-computing-global-market-report
Software As A Service Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/software-as-a-service-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model